Breaking News

Scorpius Holdings CEO Provides Corporate Update

Highlights positive developments, investments and growth.

Author Image

By: Charlie Sternberg

Associate Editor

Jeff Wolf, CEO of Scorpius Holdings Inc., an integrated CDMO, has released a letter to shareholders in which he provides a corporate update.   “Over the past several years, we have made significant investments designed to establish Scorpius as a leading biologic manufacturing CDMO,” Wolf remarks.   Notably, the company has expanded its mammalian and microbial production capability to enable it to offer a broad range of biologic manufacturing services to its customers. Its investments and ong...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters